Reduction of myocardial lipid content assessed by H1 magnetic resonance spectroscopy in dyslipidemic patients after statins
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Reduction of myocardial lipid content assessed by H1 magnetic resonance spectroscopy in dyslipidemic patients after statins ; volume:55 ; number:1 ; day:9 ; month:7 ; year:2024 ; pages:1-9 ; date:12.2024
The Egyptian Journal of Radiology and Nuclear Medicine ; 55, Heft 1 (9.7.2024), 1-9, 12.2024
- Creator
-
Elmenyawy, Eslam Elsayed Mohamed
Fadl, Hend Gamal Abu-El
Waly, Hesham Mohammed Fathy
Maaty, Abdul Razek Abdul Lateef
Abdelaziz, Hanaa Mahmoud Mohammad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43055-024-01302-2
- URN
-
urn:nbn:de:101:1-2409262120432.404800287740
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elmenyawy, Eslam Elsayed Mohamed
- Fadl, Hend Gamal Abu-El
- Waly, Hesham Mohammed Fathy
- Maaty, Abdul Razek Abdul Lateef
- Abdelaziz, Hanaa Mahmoud Mohammad
- SpringerLink (Online service)
Other Objects (12)
Statins protect diabetic myocardial microvascular endothelial cells from injury
KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment
Statins in Females
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
Myocardial ischaemic burden assessed by three-dimensional perfusion CMR - comparison with Myocardial Perfusion Scintigraphy
Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?
H1
Ticagrelor and Statins: Dangerous Liaisons?
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Statins protect diabetic myocardial microvascular endothelial cells from injury
KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment
Statins in Females
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
Myocardial ischaemic burden assessed by three-dimensional perfusion CMR - comparison with Myocardial Perfusion Scintigraphy
Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?
H1
Ticagrelor and Statins: Dangerous Liaisons?
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Statins protect diabetic myocardial microvascular endothelial cells from injury
KCNJ16-depleted kidney organoids recapitulate tubulopathy and lipid recovery upon statins treatment
Statins in Females
Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful?
Myocardial ischaemic burden assessed by three-dimensional perfusion CMR - comparison with Myocardial Perfusion Scintigraphy
Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins
Are statins anti-inflammatory?
Hepatotoxicity associated with statins
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering (MIRACL) trial: a new frontier for statins?
H1
Ticagrelor and Statins: Dangerous Liaisons?